If two Virginia Tech researchers, collaborating with the American Dental Association (ADA), are able to successfully construct a tissue engineered composite material for oral reconstructions, these dismal statistics might yield a better outcome.
The repair of the diseased tissue in these cancers often requires reconstruction of the bone, and Brian Love, Virginia Tech professor of materials science and engineering, and principal investigator on a $140,000 National Institutes for Health (NIH) grant, believes "substantially better clinical outcomes for all oral constructions could result if a more viable scaffold material were used that was capable of faster and higher quality bone formation."
Love and the team are looking at amorphous calcium phosphates (ACPs) as inorganic host materials in the rebuilding of tissue. ACPs, in the presence of cells that make bone (called osteoblasts), are believed to "more readily" provide the host material for new bone formation in tissue engineering than other choices, Love explains.
"By constructing tissue engineered composites containing ACPs, living osteoblasts, and donor materials," Love believes the result could be faster and higher quality bone formation.
The Paffenbarger Research Center of the ADA is supplying the ACP for the current studies. Aaron Goldstein of Virginia Tech's chemical engineering department is a co-principal investigator, and Drago Skrtic of the ADA Paffenbarger Research Center and Peter Shires of Virginia-Maryland Regional College of Veterinary Medicine are collaborating with Love and Goldstein. Both are also affiliated with the Virginia Tech Wake Forest School of Biomedical Engineering and Science.
In earlier studies, Love recently completed a research leave at the Dental Polymers Group of the National Institute for Standards and Technology (NIST), where he worked on photopolymers used in dentistry. Goldstein has performed post-doctoral work at Rice University's Tissue Engineering Laboratories, and has six years of cell culture and tissue engineering experience with bone marrow stromal osteoprogenitor cells at Virginia Tech. Skrtic has studied ACP precipitation, purification, and incorporation into remineralizing resins for the past 12 years. Shires' primary research interests are bone defects, osteoarthritis, and surgical repair. He has the facilities to evaluate host tissue responses to the tissue-engineered materials.
As the interdisciplinary research team better understands how bone-making cells respond to ACP, their next challenge will be to assess these re-growth characteristics in vivo.
Their work to date is currently in press for upcoming issues of the Journal of Biomaterials Science, Polymers Edition, and the Journal of Biomedical Materials Research.
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.